Wanhai Medical Pen Injector GLP-1 Solution

Wanhai Medical’s pen injector is a precision medical device designed for safe and convenient administration of Semaglutide, a GLP-1 receptor agonist used in type 2 diabetes and obesity management. Prefilled for accuracy, this disposable pen ensures consistent dosing with minimal user steps. Its ergonomic design enhances grip, while the fine needle reduces injection discomfort.

Wanhai Medical's ready-to-use injection device enables effortless subcutaneous delivery of Tirzepatide, the advanced GLP-1/GIP co-agonist for type 2 diabetes and obesity treatment. Featuring a dose-memory function, ultra-fine needle, and dose confirmation clicks, it ensures treatment accuracy while minimizing discomfort. The sleek, intuitive design supports independent patient use, with clear dose indicators preventing errors.

Wanhai Medical's pen injector is engineered for safe and convenient self-administration of Liraglutide, a potent GLP-1 receptor agonist for type 2 diabetes and obesity management. It features a precisely calibrated dosing system, ultra-thin needle, and dose-lock mechanism to ensure treatment accuracy. The compact, discreet design enhances portability and ease of use, while the visual/tactile dose confirmation reduces errors. Suitable for daily dosing, it maintains drug integrity and supports consistent therapeutic results, helping patients achieve better glycemic control and weight management with minimal injection discomfort.

Designed for effortless self-administration of Mazdutide, a next-generation GLP-1 agonist, Wanhai Medical pen injector ensures precise dosing and enhanced treatment adherence. The user-friendly pen features a hidden needle technology, dose-confirmation click, and ergonomic grip for comfortable, anxiety-free injections. Ideal for chronic metabolic therapies, it supports long-term efficacy while minimizing injection-site reactions.

Engineered for seamless self-injection of Enoglimab, Wanhai Medical's pen injector ensures accurate, consistent dosing for GLP-1 receptor agonist therapy. Featuring a low-waste, auto-disable mechanism, it maximizes drug efficiency while minimizing preparation steps. The ultra-fine needle and gradual-release technology enhance patient comfort and pharmacokinetic performance.